文献速递肝胆胰外科

ALPPS的现状与进展

[Current status and progress of ALPPS].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2025-01-01

本文综述联合肝脏分隔和门静脉结扎的二步肝切除术(ALPPS)的现状与进展。ALPPS可快速诱导余肝增生、提高肿瘤切除率,早年因并发症发生率和病死率高引发争议,经十余年发展安全性已显著改善,肿瘤学获益等问题亦基本明晰。

要点

  • ALPPS是诱导余肝增生的重要创新术式,具有余肝快速增生和肿瘤切除率高的优点。
  • 早年ALPPS因手术并发症发生率和病死率高而存在争议。
  • 历经十余年发展,ALPPS安全性已显著改善,肿瘤学获益等问题已基本明晰。

核心结论

  • ALPPS历经十余年发展,安全性已显著改善,肿瘤学获益等问题亦已基本明晰。

研究设计与样本

  • 本文为综述,阐述ALPPS的现状与进展,未报告检索范围与样本量。

主要发现

  • ALPPS具有诱导余肝快速增生和肿瘤切除率高的优点。
  • 早年ALPPS因手术并发症发生率和病死率高引发争议。
  • 历经十余年发展,ALPPS安全性已显著改善。

临床怎么用

  • 对预计余肝体积不足的肝癌患者,ALPPS是诱导余肝增生的重要创新术式选项。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Surgical resection is the mainstay of curative treatment for long-term survival of patients with liver cancer. However, many patients are excluded for surgical resection due to insufficient future liver remnant(FLR). The two-stage hepatectomy (induction of FLR hypertrophy followed by tumor resection) is one of the main treatment strategies for insufficient FLR. The new associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is an important innovative procedure for inducing FLR hypertrophy, which has the advantages of rapid and significant induction of FLR hypertrophy as well as high tumor resection rate, but it was controversial in the early years due to high postoperative morbidity and mortality. After more than 10 years of development, ALPPS has made tremendous advance. Surgical safety of ALPPS has been significantly improved, and oncological benefits and other issues have been largely clarified. This article aims to introduce the current status and progress of ALPPS. 手术切除是肝癌患者长期生存的主要治疗方式,但许多患者因为预计余肝体积不足而无法手术切除肿瘤。诱导余肝增生后再切除肿瘤的二步肝切除是预计余肝体积不足患者的主要治疗策略之一。联合肝脏分隔和门静脉结扎的二步肝切除术(ALPPS)是诱导余肝增生的一种重要创新术式,具有诱导肝脏快速增生、肿瘤切除率高等优点。但早年ALPPS也曾因手术并发症发生率和病死率高等问题引发争议。历经十余年的发展,ALPPS进展迅速,安全性已显著改善,肿瘤学获益等问题亦已基本明晰。本文对ALPPS的现状与进展进行阐述。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhou J, Peng YF. [Current status and progress of ALPPS]. Zhonghua Wai Ke Za Zhi. 2025. PMID: 40058775. doi:10.3760/cma.j.cn112139-20241203-00546

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。